Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 20008278)

1.

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H833-43. doi: 10.1152/ajpheart.00418.2009. Epub 2009 Dec 11.

2.

The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.

Kawase Y, Hajjar RJ.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):554-65. doi: 10.1038/ncpcardio1301. Epub 2008 Jul 29. Review.

PMID:
18665137
3.

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Turan B, Tuncay E, Vassort G.

J Bioenerg Biomembr. 2012 Apr;44(2):281-96. doi: 10.1007/s10863-012-9429-0. Review.

PMID:
22437738
4.

Biochemical effects of SIRT1 activators.

Baur JA.

Biochim Biophys Acta. 2010 Aug;1804(8):1626-34. doi: 10.1016/j.bbapap.2009.10.025. Epub 2009 Nov 6. Review.

5.

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease.

Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, Doganay L, Enc FY.

Med Sci Monit. 2011 May;17(5):HY5-9. Review.

6.

Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.

Sundaresan NR, Pillai VB, Gupta MP.

J Mol Cell Cardiol. 2011 Oct;51(4):614-8. doi: 10.1016/j.yjmcc.2011.01.008. Epub 2011 Jan 27. Review.

7.

A patent review of sirtuin activators: an update.

Villalba JM, de Cabo R, Alcain FJ.

Expert Opin Ther Pat. 2012 Apr;22(4):355-67. doi: 10.1517/13543776.2012.669374. Epub 2012 Mar 9. Review.

PMID:
22475539
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk